Journal of Psoriasis and Psoriatic Arthritis

Associations Between Clinical Characteristics and Magnetic Resonance Imaging of the Sacroiliac Joints and Spine: Exploratory Analysis of the Phase 4, Randomized, Placebo-Controlled STAR Study.

Pub Date : 2026-10-18 DOI: 10.1177/24755303261494534 Xenofon Baraliakos, Paul Bird, Atul Deodhar, Dafna D Gladman, Philip S Helliwell, Denis Poddubnyy, Arthur Kavanaugh, Mikkel Østergaard, Enrique R Soriano, Lai-Shan Tam, Soumya D Chakravarty, Evan Leibowitz, Cinty Gong, Oyediran Adelakun, Stephen Xu, Thomas Fuerst, Nadeem Saeed, Robert Landewé, Philip J Mease

Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials.

Pub Date : 2026-10-18 DOI: 10.1177/24755303261494526 Iain B McInnes, Linda Stein Gold, Robert Bissonnette, Mark G Lebwohl, Ofelia Reyes-Servin, Joseph Cafone, Ya-Wen Yang, Soumya D Chakravarty, Charles Iaconangelo, Shu Li, Tasneam Shagroni, Karissa Lozenski, April W Armstrong, Joseph F Merola

Effects of Switching From Deucravacitinib to Tildrakizumab in Psoriasis: A 28-Week Real-World Study.

Pub Date : 2026-10-10 DOI: 10.1177/24755303261497686 Yohei Takahashi, Teppei Hagino, Manami Yoneyama, Mizuki Shiba, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda